Sauer, Corinne; Sauer, Robert - Jerusalem Institute for Market Studies (JIMS) - 2005
This paper argues that drugs are expensive not because of a lack of competition among research-based pharmaceutical companies, but because of a lack of competition in the drug approval process. Lack of competition in the drug approval process has led to exceedingly high drug development costs....